Navigation Links
Abaxis Reports Financial Performance with Record Sales for the Second Quarter of Fiscal 2011
Date:10/26/2010

call may be affected by risks and uncertainties, including, but not limited to, those related to the market acceptance of the company's products and the continuing development of its products, required United States Food and Drug Administration clearance and other government approvals, risks associated with manufacturing and distributing its products on a commercial scale free of defects, risks related to the introduction of new instruments manufactured by third parties, risks associated with entering the human diagnostic market on a larger scale, risks related to the protection of the company's intellectual property or claims of infringement of intellectual property asserted by third parties, risks related to condition of the United States economy, risks involved in carrying of inventory and other risks detailed under "Risk Factors" in Abaxis' Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2010 and Abaxis' other periodic reports filed from time to time with the United States Securities and Exchange Commission.  Forward-looking statements speak only as of the date the statements were made.  Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.

Financial Tables on Following PagesABAXIS, INC.Condensed Consolidated Statements of Income(in thousands, except per share data)(Unaudited)Three Months EndedSix Months EndedSeptember 30,September 30,2010200920102009Revenues

$
35,277

$
30,262

$
70,230

$
59,887Cost of revenues

15,527

12,411

30,696

24,881Gross profit

19,750

17,851

39,534

35,006Operating expenses:   Research and development

3,296

2,594

6,374

5,167   Sales and marketing

8,408

7,582

17,041

13,942   General and administrative

2,652

2,689

4,776

5,187Total operati
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Abaxis to Report Second Quarter Fiscal 2011 Financial Results Tuesday, October 26, 2010
2. Abaxis, Inc. to Present at Sidoti & Companys Ninth Annual West Coast Institutional Investor Forum
3. Abaxis Reports Record Revenues for the Third Quarter of Fiscal 2010
4. Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference
5. Abaxis, Inc. to Present at the Sidoti & Company Second Annual New York Institutional Investor Forum
6. Abaxis to Report Second Quarter Fiscal 2010 Financial Results Tuesday, October 27, 2009
7. ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test
8. Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
9. Assured Pharmacy Reports Same Store Sales for the Month of September 2010
10. Danaher Reports Record Third Quarter 2010 Results
11. Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... and FT LAUDERDALE, Florida , ... ("OrbusNeich"), a designer, developer, manufacturer and marketer of innovative medical ... on May 13, 2015, it prevailed in a final opposition ... Patent EP 1 341 482 - STENT HAVING HELICAL ELEMENTS ... review in the EPO and has been upheld as a ...
(Date:7/1/2015)... SAN DIEGO , July 1, 2015  MEI Pharma, ... the clinical development of novel therapies for cancer, announced today ... Executive Officer, will present at the inaugural Cantor Fitzgerald Healthcare ... time from Le Parker Meridien in ... can be accessed at www.meipharma.com . A replay will ...
(Date:7/1/2015)... Lupin , ... Number of MPP Sub-licensees to Fourteen Companies   ... the rapid expansion of its network of generic manufacturers to ... develop MPP-licensed antiretrovirals (ARVs). New companies Lupin and Strides Arcolab ... HIV medicine the MPP licensed from ViiV Healthcare two months ...
Breaking Medicine Technology:OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3
(Date:7/2/2015)... ... 02, 2015 , ... Cs &A, the leader in Semi ... release and publication of their newest offering to complement the existing line of ... , Designed in support of coverage for the full spectrum of Semi Timing ...
(Date:7/1/2015)... ... 2015 , ... A June 19th article by the Associated Press discussed a recent ... the cost of medical care, specifically for seniors. Medicare recently completed the first year of ... $25 million. Medicare’s chief medical officer, Dr. Patrick Conway said that “If we can keep ...
(Date:7/1/2015)... ATLANTA, GEORGIA (PRWEB) , ... July 01, 2015 ... ... the Institute for Biomedical Sciences at Georgia State University and a Georgia Research ... federal grant to develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant ...
(Date:7/1/2015)... ... 01, 2015 , ... For decades, researchers in the genetics field have theorized ... brain, never changing after development in the womb. Now, researchers from the Icahn School ... cells throughout life – a process which helps to switch genes on and off. ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... care, specialty, combo, and compounding pharmacy operations, announces the most recent positioning of ... Cardinal Health RBC event at the Venetian Las Vegas, Nevada. During ...
Breaking Medicine News(10 mins):Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 2Health News:Article Announcing Medicare’s Cost Cutting Suggestions Shines Brightly on House Call Medicine, Comments Dr. Michael Farzam 3Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4
... ... Association (DIA) will host Personalized Medicine: Biomarkers and Diagnostics in Drug Development, Regulatory Approval, ... ... 1, 2009 -- The Drug Information Association (DIA) will host Personalized ...
... , , Campaign depends ... , WASHINGTON, Sept. 1 The U.S. Department ... in the 4th annual Drug-Free Work Week, which will occur Oct. ... emphasizes the importance of drug-free workplace programs to help prevent workplace ...
... invasive procedure shaves off lesions, researchers say , TUESDAY, ... esophagus can be treated effectively by less invasive, organ-sparing ... is good news, as esophageal cancer arising from Barrett,s ... cancer in the United States, and 90 percent of ...
... be a way around the harsh skin toxicity associated with ... online this week in Cancer Biology and Therapy ... at Jefferson. Cetuximab (Erbitux) is a monoclonal antibody ... (EGFR). It is widely used to treat colorectal cancer and ...
... recent study published in the Journal of Cancer ... smoking and breast cancer. What makes this study unique ... and BRCA2 gene mutations, which predispose women to breast ... were excluded to allow researchers to concentrate on lifestyle ...
... , CHICAGO, Sept. 1 With so ... pavement more often in the hunt for a new job! The ... their face - during an interview is foot pain. "Plenty of ... AnkleNFootCenter.com. "And dress shoes are the worst, particularly for women," adds ...
Cached Medicine News:Health News:DIA Conference to Explore The Science and Scope of Personalized Medicine 2Health News:U.S. Labor Department announces dates for 4th annual Drug-Free Work Week 2Health News:New Therapy Spares Organ in Early Esophageal Cancer 2Health News:Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs 2Health News:Breast cancer: Risk increases for smokers and overweight women 2Health News:Hitting the Pavement? Make Sure Your Feet (And Your Shoes) Are Ready. 2
The seed alignment tray aligns seeds and spacers for easy access to be picked up by the SeedVac™. It also interfaces with the seed sterilization and sorting tray for protection from radiation....
MT-BT-5011-25 Prostate seeding needle (set of 25 unloaded needles).,MT-BT-5011-P Prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seedin...
... ACMI™ offers five classes of ... vaporization, cutting loops, knife, roller bar ... are the only electrodes specifically integrated ... surgical tissue removal with minimal bleeding, ...
... Nephroscope, with a stainless steel shaft, combines ... lumbotome, for precise pre-cutting of scar tissue, ... access. The 13.5 Fr. oval working channel ... and lithotripsy probes, and allows a high ...
Medicine Products: